Furthermore, our results demonstrate that ISL decreases ROS levels, downregulates NOX2, and upregulates antioxidant gene expressions in T2D mouse aortas and IL-1β-treated endothelial cells. The gene discussed is CYBB; the disease is type 2 diabetes mellitus.